Interestingly, the up-regulation of PAQR4 was revealed to have a tumorigenic effect also in breast cancer [119,120], lung cancer [121], and is also reported to be associated with poor survival outcome in prostate cancer [122]. Here, PAQR4 is linked to breast cancer.